Dr. Ezrokhi earned his PhD from Brown University in molecular biology (1999).
Dr. Ezrokhi primarily works in the field of Molecular Biology and oversees all research and development in this area.
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
